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Abstract
Background: In 2013 the Dutch guideline for management of medically unexplained symptoms (MUS) was
published. The aim of this study is to assess medical care for patients with persistent MUS as recorded in their
electronic medical records, to investigate if this is in line with the national guideline for persistent MUS and
whether there are changes in care over time.
Methods: We conducted an observational study of adult primary care patients with MUS. Routinely recorded health
care data were extracted from electronic medical records of patients participating in an ongoing randomised controlled
trial in 30 general practices in the Netherlands. Data on general practitioners’ (GPs’) management strategies during MUS
consultations were collected in a 5-year period for each patient prior. Management strategies were categorised
according to the options offered in the Dutch guideline. Changes in management over time were analysed.
Results: Data were collected from 1035 MUS consultations (77 patients). Beside history-taking, the most frequently used
diagnostic strategies were physical examination (24.5%) and additional investigations by the GP (11.1%). Frequently used
therapeutic strategies were prescribing medication (24.6%) and providing explanations (11.2%). As MUS symptoms
persisted, GPs adjusted medication, discussed progress and scheduled follow-up appointments more frequently. The
least frequently used strategies were exploration of all complaint dimensions (i.e. somatic, cognitive, emotional,
behavioural and social) (3.5%) and referral to a psychologist (0.5%) or psychiatrist (0.1%).
Conclusions: Management of Dutch GPs is partly in line with the Dutch guideline. Medication was possibly prescribed
more frequently than recommended, whereas exploration of all complaint dimensions, shared problem definition and
referral to mental health care were used less.
Keywords: Disease management, General practice, Medically unexplained symptoms, Primary health care
Background
Medically unexplained symptoms (MUS), i.e. physical
symptoms that cannot entirely be accounted for by a
known somatic disease, are extremely common in pri-
mary care [1, 2]. Although most such symptoms are
self-limiting, in some cases they persist and impair pa-
tients’ functioning [3]. In the latter case, persisting MUS
may meet diagnostic criteria for (undifferentiated)
somatoform disorder of the psychiatric classification sys-
tem DSM-IV [4]. Since the introduction of DSM-5,
somatoform disorders have been replaced by somatic
symptom disorders [5]. The main criteria for somatic
symptom disorder no longer require the nature of
physical symptoms to be unexplained, but focus on
maladaptive cognitions, emotions and/or behaviour with
respect to the physical symptom(s).
The prevalence of persistent MUS, such as those
classified as somatoform disorders, is 3–10% in general
practice [6–8]. Persistent MUS are disabling and are
associated with high rates of comorbid mental health
disorders [6, 9, 10]. There are high direct and indirect
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health care costs due to increased health care use and
productivity loss due to sickness absence [11].
Previous research shows that GPs may view MUS pa-
tients as challenging, as it can be difficult for the GP to
exclude the possibility of a serious illness and at the same
time satisfy patients’ concerns about their health [12].
GPs’ may develop a sense of uncertainty in their profes-
sional knowledge [12–14] and patients may be left feeling
that their symptoms are not being taken seriously [13].
To aid GPs in the management of patients with MUS,
the Dutch College of General Practitioners published a
guideline in 2013 [15]. Previous guidelines for MUS have
also been published in Germany [16] and England [17].
The diagnostic recommendations in the Dutch guideline
include ample exploration of all dimensions of com-
plaints (i.e. somatic, cognitive, emotional, behavioural
and social dimensions) and a thorough physical examin-
ation. The GP should be cautious with additional investi-
gations and diagnostic referrals and should evaluate the
severity of the symptoms or a change in symptoms over
time. The therapeutic recommendations describe a
stepped-care process in three steps, in which the GP
starts with the mildest possible treatment and intensifies
treatment when there are no adequate results.
It is unclear what current management for persisting
MUS entails and whether this is in line with the Dutch
guideline. Although GPs’ perceptions about giving expla-
nations to patients with persistent MUS have previously
been investigated in a Dutch focus group study, the ac-
tual management strategies were not described [18].
The aim of this descriptive study is to gain more
insight into the management of adult patients with per-
sistent MUS that meet criteria for an undifferentiated
somatoform disorder in Dutch general practice and its
potential change in time, as recorded in the patients’
medical records. We also aim to investigate to what ex-
tent this care is in line with the national guideline pub-
lished by the Dutch College of General Practitioners.
Method
Study design and patient selection
We analysed the longitudinal electronic medical record
data of persons participating in an ongoing randomised
controlled trial (RCT) called the CIPRUS study. The
CIPRUS study aims to establish the effectiveness of
treatment of undifferentiated somatoform disorder by a
mental health nurse practitioner (MHNP) within general
practice, versus usual care. The design of the CIPRUS
study has been described elsewhere in more detail [19].
Potential participants were identified by running a
search of the electronic medical records for patients who
had consulted their GP at least twice in the previous
3 months with one or more complaints from the Rob-
bins list [20]. The Robbins list consists of 23 physical
symptoms that are associated with functional somatic
syndromes. GPs then checked the selected patients to
verify that these patients indeed had MUS according to
them, and excluded patients who fulfilled one or more
exclusion criteria. Exclusion criteria were: presence of a
medical or psychological disorder explaining the symp-
toms, presence of a severe psychiatric disorder, currently
receiving psychological treatment for MUS, having poor
language skills or handicap that prevented patients from
understanding the intervention. After patients were veri-
fied as having MUS by their GP, they were interviewed
using a structured clinical interview (SCID-I) in order to
determine whether they fulfilled the DSM-IV criteria for
undifferentiated somatoform disorder (USD) [21]. Those
fulfilling the criteria for USD were included in the
current study. All participating patients gave written
informed consent to extract data from their electronic
medical records. In the current study, we used data from
patients participating in the usual care group of the
CIPRUS study. We used data from the group of MUS
patients receiving usual care because we wanted to know
which care patients received. Because we had already
identified these patients as having MUS we used the data
from this group. Obviously we could not use data from
the intervention group, as the intervention consisted of
a number of scheduled meetings with the MHNP within
the general practice, which would also be recorded in
the electronic medical records. This data would, there-
fore, not only reflect usual care, but also care provided
due to being part of the intervention group of our trial.
Data extraction
Data were manually extracted by 3 researchers from
electronic medical records of all participating patients
between 21 November 2016 until 31 August 2017 in 30
participating general practices. Data were extracted for
all MUS consultations in the 5-year time period for each
patient prior to the search date. Data were collected
from fields for prescription, medical tests and referrals,
and from the GPs’ free text notes. Extracted data con-
sisted of the date of the consultation, International Clas-
sification of Primary Care (ICPC) code corresponding to
the consultation, and the management strategy of the
GP, i.e. GPs’ own notes in the electronic medical records
on what was carried out during the consultation and
what they were planning or had arranged to do as a next
step. For persons who were younger than 18 years of age
during the 5-year time period, data were only collected
from age 18 onward. MUS consultations were defined as
consultations in which the GPs used ICPC codes that
corresponded with the symptoms from the Robbins list
(Table 1) [20]. Because there are no suitable correspond-
ing ICPC codes for the symptoms ‘restlessness’ and
‘thoughts slower’, these two items from the Robbins list
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were omitted. Data from consultations that were not
coded with ICPC codes corresponding to the Robbins
list, but where the GP had noted ‘MUS’ or ‘somatisation’
were also collected.
Data categorisation
After collection, the extracted data on management were
categorised by one researcher (KS) according to the
options for diagnosis and treatment in the current Dutch
GP guideline [15]. The categories from the guideline
used for classifying diagnostic strategies were explor-
ation of all complaint dimensions, physical examination
and additional diagnostic testing within and outside gen-
eral practice (diagnostic referral). The categories used
for classifying treatment strategies were shared problem
definition, education and explanation, advice, treatment
with medication, setting up a time contingent plan,
scheduling follow-up appointments, referral to other
primary care providers, and referral to secondary care
[15]. Within primary care a patient can be referred to
other care providers such as a (psychosomatic) physio-
therapist or exercise therapist, mental health nurse
practitioner, primary care social psychiatric nurse or
primary care psychologist (e.g. trained in cognitive be-
havioural therapy) [15].
Data analysis
Data were analysed using SPSS version 22 for Windows.
We used descriptive statistics to describe the study
population and the management strategies. In order to
determine whether there were any trends of providing
various management strategies over time, we used
cross-tabs and the chi-square test for trend.
Results
Figure 1 presents a flow chart of patients included in
this study. The control group of the CIPRUS study
consisted of 96 patients in total. Seventeen patients
dropped out of the study, and did not give permission to
collect data from their medical records. Therefore, data
were collected from 79 patients. For two patients, no
information on MUS consultations was found in their
electronic medical records. Therefore, data from 77 pa-
tients were available. The GPs registered a total of 1035
MUS consultations for these patients, of which 13.6%
took place before 2013, the year in which the Dutch GP
guideline was published.
Characteristics of patients with persistent MUS
Of the 77 patients, 80.5% were female. The mean age
was 50 (SD: 17.1, range: 19–89). Over the 5 year period,
the mean number of MUS consultations was 13 (SD: 17,
range: 1–130), resulting in an average of 2.6 consulta-
tions a year. The symptoms patients presented with are
provided in Table 1. The most frequently recorded
symptoms were back pain (17,3%), weakness or fatigue
(12,8%), extremity pain (11%) and sleep disturbance
(10,2%). No consultations had codes for loss of appetite
and gas or bloating. Seventy-one consultations (6,9%)
were coded with codes other than those that appear on
the Robbins list, however the GP had referred to MUS
in these consultations. The codes used in this category
were hysteria/hypochondria (ICPC code P75), neurasthe-
nia/stress (P78), spastic colon/irritable bowel syndrome
(D93), and ‘no disease’ (A97).
Recorded management strategies
GPs varied in the way they recorded what was done dur-
ing the consultations. This varied per GP as well as per
patient and per consultation. Table 2 provides examples
of data extracted from electronic medical records of
three patients. There are 2 examples of brief records
Table 1 Robbins list and corresponding ICPC codes
Symptoms from
the Robbins list
Corresponding
ICPC codes
Number of
consultations (%)
Back pain L01, L02, L03 179 (17.3)
Joint pain L20 28 (2.7)
Extremity pain L18a 114 (11.0)
Headaches N01, N02 69 (6.7)
Weakness/fatigue A04 132 (12.8)
Chronic fatigue syndrome A04.01 65 (6.3)
Sleep disturbance P06a 106 (10.2)
Difficulty concentrating P20 2 (0.2)
Loss of appetite T03 0 (0.0)
Weight change T07, T08 9 (0.9)
Restlessness N/A N/A
Thoughts slower N/A N/A
Chest pain L04 38 (3.7)
Shortness of breath R02 7 (0.7)
Palpitations K04 24 (2.3)
Dizziness N17a 29 (2.8)
Lump in throat R21a 28 (2.7)
Numbness N06a 5 (0.5)
Nausea D09 16 (1.5)
Loose bowels D11 20 (1.9)
Gas or bloating D08 0 (0.0)
Constipation D12 36 (3.5)
Abdominal pain D01 57 (5.5)
Other (not part of
the Robbins list)
A97, D93, P75, P78 71 (6.9)
aincluding subcodes
N/A not applicable
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(≤10 words), 2 examples of medium-length records (11–
30 words) and 2 examples of long records (≥31
words).The table also illustrates how these were cate-
gorised according to the GP guideline categories. An
overview of the strategies the GPs used in the 1035 con-
sultations is provided in Table 3. The most common
diagnostic strategies were physical examination (24.5%
of consultations, range among GPs 7.0–66.7%) and add-
itional investigations within the GP practice (14.6%,
range 0–50%). Of the additional investigations, labora-
tory tests such as various blood, urine and feces tests
were done most frequently (11.1%, range 0–37.5%).
Symptom exploration was recorded in 3.5% of the con-
sultations (range 0–20.0%) and found among 40% of the
GPs. Having administered the recommended symptom
checklist enquiring about distress, depression, anxiety and
somatisation symptoms, the 4-Dimensional Symptom
Questionnaire (4DSQ) [22], was only recorded once (0.1%).
The most common treatment strategies were treat-
ment with medication (24.6%, range 0–62.5%), followed
by discussing progress (16.2%, range 0–41.5%), schedul-
ing follow-up appointments (11.8%, range 0–33.3%),
vitamin pills/injections (11.7%, range 0–36.8%, recorded
by less than a quarter of the GPs, mainly in the same
patients), providing education and explanation (11.2%,
range 0–35.7%) and giving advice (10.8%, range 0–
42.3%). Wait and see strategies were also recorded
frequently (9.4%, range 0–40.0%). Medication requiring
a prescription was prescribed most (at least 19.4% of all
treatment strategies, range 0–40.0%). NSAIDs were
prescribed most frequently (3.6% of all treatment strat-
egies, range 0–13.5%), followed by psychopharmacologi-
cal medication (3.4% of all treatment strategies, range 0–
20.0%, recorded by almost half of the GPs) and opioids
(3.0% of all treatment strategies, range 0–11.5%, also re-
corded by almost half of the GPs).
Referrals to a psychologist (0.5%, range 0–7.7%, re-
corded by 17% of the GPs) or a psychiatrist (0.1%),
formulation of a shared problem definition (0.4%,
range 0–7.7%, recorded by 10% of the GPs) and
setting up a time contingent plan (0.1%) were man-
agement strategies that were used the least often.
When referrals to secondary care were documented,
it was often unclear whether the referral was for diag-
nostic or treatment purposes. Therefore, a category
‘referral to secondary care (unclear for diagnostics or
treatment)’ was added. Finally, of the 44 management
strategies categorised as ‘other’, GPs coded 28
Fig. 1 Flow chart of MUS patients. CIPRUS study = Cognitive-behavioural Intervention for PRimary care patients with Undifferentiated
Somatoform disorder
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consultations (2.7%) with ‘talk’, ‘listening ear’ and
‘encouragement’.
Management strategies across time
We conducted chi-square tests for trend for the largest
categories of management strategies (n of consultations
≥75). Over the 5 year time period, there appeared to be
significant trends in the course of ‘giving advice’ χ2 (1) =
5.73, p = 0.017, ‘medication adjustment’ χ2 (1) = 11.67, p
= 0.001, ‘discussing progress’ χ2 (1) = 11.31, p = 0.001,
‘scheduling follow-up appointments’ χ2 (1) = 10.75, p =
0.001 and ‘contact if necessary’ χ2 (1) = 4.11, p = 0.043. In
all the above categories, the proportion of consultations
in which the management strategies concerned were
provided, increased over time. For all of the above man-
agement strategies except ‘contact if necessary’ there was
a small decrease in percentage of the management strat-
egy used within consultations after the first year, after
which the percentages increased again. For ‘contact if
necessary’, the percentage of the consultations increased
steadily across time. There were no significant trends
over time for the other management strategies.
Discussion
Summary
The most frequent management strategies recorded by
Dutch GPs included diagnostic procedures such as phys-
ical examinations and additional investigations, and
therapeutic procedures such as prescribing medication,
discussing progress and providing education, explanation
and advice. Other strategies that focus more on listening
to the patient and involving patients in their own diag-
nostic and therapeutic process, and decision making,
such as ‘exploration of all complaint dimensions’, ‘shared
problem definition’, and ‘shared plan for symptom man-
agement’ did not seem to be adopted as frequently.
These latter management strategies are especially
Table 2 Examples of categorisation of data extracted from electronic medical records
Patient Length of
record
Information extracted
from medical records
Categorised as
113 ≤10 words Had a talk. Gave explanation. Diagnostic:
None
Therapeutic:
- Education and explanation
- Discussing progress
- Other: “talk”
171 ≤10 words Physical examination, referral to neurologist Diagnostic:
- Physical examination
Therapeutic:
- Referral to secondary care
(unclear for diagnostics or
treatment): neurologist
115 11–30 words Explained that I don’t know whether a scan is indicated,
but that due to the long duration of complaints we can
ask for the orthopedist’s opinion: referral
Diagnostic:
- Diagnostic referral
Therapeutic:
- Education and explanation
123 11–30 words Stop tramal, start fentanyl patch, and follow up appointment
after 2 weeks, is allergic to diclofenac, developed a rash, fentanyl
patch 12 mcg/hr. 5 pieces
Diagnostic:
None
Therapeutic:
- Medication adjustment: discontinuation
- Prescribed medication: opioids
- Follow-up appointment
158 ≥31 words Carried out physical examination. Exploration. Does not feel
reassured despite good lab results and echo abdomen. Will
go to exercise therapist and an optometrist for visual test.
Will return in a month for an evaluation. If there is insufficient
improvement, referral to a psychiatrist. In my opinion no
indication of physical cause. Patient will also fill in a diary with
symptoms (because complaints are very inconsistent). Explanation
when to return sooner.
Diagnostic:
- Exploration of symptoms
- Physical examination
- Discussing test results
Therapeutic:
- Education and explanation
- Symptom diary
- Discussing progress
- Follow-up appointment
165 ≥31 words Gave explanation: No somatic problem, no reason to be extra
vigilant with normal heartbeat. Talked about the option to talk
to the behaviour specialist, is going to do this. Will go to physiotherapist
to learn not to focus on his normal heartbeat. Wants to go there
as well because wants to hear from a professional whether everything
is OK during a workout, prefers not to start a long treatment program
(psychosomatic physiotherapy?)
Diagnostic:
None
Therapeutic:
- Education and explanation
- Referral within primary care: other
GP consulting another health professional:
other
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Table 3 Overview of management strategies
Management strategies n of consultations a (%) b n of patients
Diagnostic strategies
Exploration of symptoms 36 (3.5) 22
Physical examination 254 (24.5) 67
Additional investigations within GP practice 151 (14.6) 61
Laboratory tests 115 (11.1) 57
ECG 17 (1.6) 14
X-ray 22 (2.1) 16
Echography 7 (0.7) 7
Other 7 (0.7) 7
Diagnostic referral 34 (3.3) 27
Discussing test results 62 (6.0) 39
Therapeutic strategies
Shared problem definition 4 (0.4) 4
Education and explanation 116 (11.2) 46
Advice 112 (10.8) 45
Lifestyle/dietary advice 53 (5.1) 31
Physical exercise advice 52 (5.0) 28
Other advice 17 (1.7) 13
Symptom diary 12 (1.2) 10
Shared plan for symptom management 48 (4.6) 28
Setting up a time contingent plan 1 (0.1) 1
Discussing/giving advice about medication 97 (9.4) 35
Medication 255 (24.6) 65
Over the counter medication (OTC) 69 (6.7) 30
Prescribed medication 201 (19.4) 62
NSAIDs 37 (3.6) 24
Opioids 31 (3.0) 19
Psychopharmacological medication 35 (3.4) 20
Sleeping medication 25 (2.4) 15
Antibiotics 7 (0.7) 6
Other 83 (8.0) 44
Unclear OTC or prescribed medication 6 (0.6) 5
Vitamin pills/injections 121 (11.7) 12
Medication adjustment 71 (6.9) 29
Dose increase 22 (2.1) 15
Dose reduction 18 (1.7) 13
Discontinuation 37 (3.6) 21
Refill prescription 28 (2.7) 11
Referral within primary care 47 (4.5) 31
Physiotherapist 25 (2.4) 18
Mental health nurse practitioner 14 (1.4) 12
Other 9 (0.9) 9
Physiotherapist appointment 27 (2.6) 20
Mental health nurse practitioner appointment 29 (2.8) 8
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important for MUS patients [23]. Patients were also
rarely referred to a psychologist or psychiatrist.
As the symptoms lasted longer, GPs tended to adjust
medication more frequently, discuss progress more
often, schedule more follow-up appointments and
encourage patients more to contact the practice if
necessary.
When comparing these strategies to the recommenda-
tions in the Dutch guideline, we can conclude that GPs
partly used management strategies recommended by the
guideline but several essential strategies were missing.
This may possibly reflect either the GPs’ or the patients’
reluctance to seek mental health care for complaints that
are perceived to be primarily physical. However, another
reason could be that GPs in our sample were not suffi-
ciently familiar with the guideline yet, since the guideline
was published during the data extraction period. Even if
GPs were familiar with the guideline, it may have taken
some time to get used to the new approach, and they
may not have started applying strategies, such as explor-
ation of all complaint dimensions, with patients whom
they had already seen often before.
Our findings could, however, also point to underre-
porting of these, more ‘conversation-like’ management
strategies. Recording behaviour varied widely across
GPs, so it is impossible to know whether the strategy
was not provided or not recorded. Due to time con-
straints, GPs may only put the more objective manage-
ment strategies such as results of physical examinations,
additional investigations and medication prescriptions in
the medical records.
Comparison with existing literature
Several studies investigated management of MUS in
other countries. A Norwegian study found that the
majority of Norwegian GPs offered supportive counsel-
ling (64%), followed by prescribing medication (24%)
and additional tests or referrals (20%) [8]. In our sample,
the rates for prescription of medication (24%) and add-
itional testing or referral (18%) were similar.
An Italian study found that Italian GPs mostly pro-
vided reassurance and support, listened to the patient,
prescribed medication, ordered further medical tests and
provided information [12]. In our study, prescribing
medication, doing further testing and providing informa-
tion were also among the most commonly used strat-
egies, however offering reassurance and support and
listening to the patient were recorded less frequently.
Although the GPs in our study coded 2,7% of their
consultations as ‘having a talk’, ‘listening ear’ and
Table 3 Overview of management strategies (Continued)
Management strategies n of consultations a (%) b n of patients
Referral to secondary care for treatment 26 (2.5) 18
Medical specialist 14 (1.4) 9
Rehabilitation 15 (1.4) 13
Referral to secondary care (unclear for diagnostics or treatment) 46 (4.4) 31
Rheumatologist 11 (1.1) 10
Neurologist 10 (1.0) 9
Gastroenterologist 7 0.7) 6
Internist 6 (0.6) 6
Psychiatrist 1 (0.1) 1
Other 12 (1.1) 12
Referral to a psychologist 5 (0.5) 5
GP consulting another health professional 46 (4.4) 22
Colleague GP 21 (2.0) 6
Secondary care medical specialist 12 (1.2) 9
Other 13 (1.3) 10
Discussing progress 168 (16.2) 52
Follow-up appointment 122 (11.8) 51
Contact if necessary 87 (8.4) 41
Wait and see 97 (9.4) 38
Other 44 (4.3) 26
Unspecified 41 (4.0) 1
aDoes not add up to 1035 because GPs recorded more than one ICPC codes during one consultation
bDoes not add up to 100% because GPs recorded more than one ICPC codes during one consultation
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‘encouragement’, ‘listening to the patient’ was not one of
the categories that we used in our classification of man-
agement strategies. Also, not all GPs may record their
listening behaviour as such in the medical records.
In the dental field adherence to clinical practice guide-
lines has been found to be up to 72% on average [24].
GPs also do not fully adhere to clinical practice guide-
lines [25, 26]. GPs report that they are aware of the
guidelines, but find it difficult to implement them
with all individual patients, as they may feel that the
guideline is not always fitting. GPs may therefore pre-
fer to provide personalized care and let the patients
have the final say in their treatment [25, 27]. This
may also apply to the GPs in our study.
Strengths and limitations
To the best of our knowledge this is the first study to
investigate care for persons with MUS in such detail. A
strength of this study is that we used real-world data dir-
ectly from electronic medical records. We were therefore
able to collect detailed information about every MUS
consultation. Furthermore, we did not rely on self-report
instruments such as surveys or interviews taken from
GPs. This possibly led to having gathered more ‘object-
ive’ data, free from various kinds of bias such as recall
bias. Another strength is that the choice of categories
for classifying management strategies was based on the
current Dutch guideline, which provided clear classifica-
tion options beforehand. At the same time, it must be
noted that the guideline is a best practice statement,
which is based on meta-analyses of high-quality
randomized controlled trials where possible, but is not
always the case. As a part of the recorded consultations
took place before the guideline was published, a longer
period of time is needed to draw firmer conclusions
regarding adherence to the guideline.
Another limitation of this study is that by using
electronic medical records our data were completely
dependent on the registering behaviour of the GPs, which
varied in amount of detail and coding. If the GP did not
record certain management strategies or symptoms in a
consultation, these data were missing. Our data, therefore,
do not necessarily reflect what was actually done during
the consultation, rather what was done and recorded. A
comparative study with recordings of patients with and
without USD, and comprehensive recording of all types of
management strategies by GPs or videotaped consulta-
tions would be helpful in gaining thorough insight in their
management and subsequent recording [28, 29].
A final limitation is that it was not possible to decide
which consultation was the first consultation in the
course of one or more MUS episodes. Because of this,
all consultations were analysed as if they are independ-
ent. However, this is usually not the case. The policy of
the GP can depend on the findings and results from pre-
vious consultations.
Conclusions
This is the first study that explores the primary care data
of Dutch patients with MUS. GPs use standardised
management strategies for persistent MUS, but seem to
prescribe medication possibly more frequently and
explore symptoms and refer to mental health care less
frequently than desirable. Over time they seemed to
adopt more monitoring and supportive management
strategies for the same patient. When seeing patients
with MUS, GPs should consider exploring cognitive,
emotional, behavioural and social dimensions of MUS
besides the somatic dimension, involving the patient
more in the problem definition and treatment plan, re-
ferring to a mental health nurse practitioner within the
practice, mental health care outside the practice and
thorough recording in medical records.
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